Your browser doesn't support javascript.
loading
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.
Szarek, Michael; Bhatt, Deepak L; Steg, Ph Gabriel; Cannon, Christopher P; Leiter, Lawrence A; McGuire, Darren K; Lewis, Julia B; Riddle, Matthew C; Voors, Adriaan A; Metra, Marco; Lund, Lars H; Komajda, Michel; Testani, Jeffrey M; Wilcox, Christopher S; Ponikowski, Piotr; Lopes, Renato D; Banks, Phillip; Tesfaye, Eshetu; Ezekowitz, Justin A; Verma, Subodh; Pitt, Bertram.
Afiliação
  • Szarek M; CPC Clinical Research and University of Colorado Anschutz Medical Campus, Aurora, Colorado, and State University of New York Downstate School of Public Health, Brooklyn, New York (M.S.).
  • Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts (D.L.B., C.P.C.).
  • Steg PG; Université de Paris, French Alliance for Cardiovascular Trials, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, INSERM Unité 1148, Paris, France (P.G.S.).
  • Cannon CP; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts (D.L.B., C.P.C.).
  • Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, and University of Toronto, Toronto, Ontario, Canada (L.A.L., S.V.).
  • McGuire DK; University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas, Texas (D.K.M.).
  • Lewis JB; Vanderbilt University, Nashville, Tennessee (J.B.L.).
  • Riddle MC; Oregon Health & Science University, Portland, Oregon (M.C.R.).
  • Voors AA; University of Groningen-University Medical Center Groningen, Groningen, the Netherlands (A.A.V.).
  • Metra M; Azienda Socio Sanitaria Territoriale Spedali Civili and University of Brescia, Brescia, Italy (M.M.).
  • Lund LH; Karolinska Institutet, Solna, Sweden (L.H.L.).
  • Komajda M; Paris Sorbonne University and Groupe Hospitalier Paris Saint Joseph, Paris, France (M.K.).
  • Testani JM; Yale University, New Haven, Connecticut (J.M.T.).
  • Wilcox CS; Georgetown University, Washington, DC (C.S.W.).
  • Ponikowski P; Wroclaw Medical University, Wroclaw, Poland (P.P.).
  • Lopes RD; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina (R.D.L.).
  • Banks P; Lexicon Pharmaceuticals, The Woodlands, Texas (P.B., E.T.).
  • Tesfaye E; Lexicon Pharmaceuticals, The Woodlands, Texas (P.B., E.T.).
  • Ezekowitz JA; University of Alberta and Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada (J.A.E.).
  • Verma S; Li Ka Shing Knowledge Institute, St. Michael's Hospital, and University of Toronto, Toronto, Ontario, Canada (L.A.L., S.V.).
  • Pitt B; University of Michigan, Ann Arbor, Michigan (B.P.).
Ann Intern Med ; 174(8): 1065-1072, 2021 08.
Article em En | MEDLINE | ID: mdl-34152828
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glicosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glicosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article